WHO stops drug trial over death rate concerns
2020-05-27 00:00
The World Health Organization said on Monday that it has suspended the trial of hydroxychloroquine as a drug to be used in the treatment of COVID after an article in medical journal The Lancet suggested it caused a relatively high death rate. Launched by the WHO and its partners, the Solidarity Trial initiative aims to evaluate the safety and efficacy of four drugs and drug combinations, including hydroxychloroquine, against the virus. More than  hospitals in  countries are actively recruiting patients and so far nearly , patients from  countries have been enrolled.                                                                                                                                                                                                                                                                           !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html